| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Jeff W M Bulte | Q90859894 |
| Dara L Kraitchman | Q92782792 | ||
| P433 | issue | 7 | |
| P921 | main subject | iron | Q677 |
| contrast agent | Q6849688 | ||
| P304 | page(s) | 484-499 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | NMR in Biomedicine | Q3061252 |
| P1476 | title | Iron oxide MR contrast agents for molecular and cellular imaging | |
| P478 | volume | 17 |
| Q48507624 | 19F-perfluorocarbon-labeled human peripheral blood mononuclear cells can be detected in vivo using clinical MRI parameters in a therapeutic cell setting |
| Q36911124 | A New Method for Preparing Mesenchymal Stem Cells and Labeling with Ferumoxytol for Cell Tracking by MRI |
| Q92864498 | A New Potential Contrast Agent for Magnetic Resonance Imaging: Iron Oxide-4A Nanocomposite |
| Q28598164 | A computational study of cancer hyperthermia based on vascular magnetic nanoconstructs |
| Q33392045 | A new method for the aqueous functionalization of superparamagnetic Fe2O3 nanoparticles |
| Q34927786 | A new nano-sized iron oxide particle with high sensitivity for cellular magnetic resonance imaging |
| Q51608260 | A novel one-step synthesis of Gd3+-incorporated mesoporous SiO2 nanoparticles for use as an efficient MRI contrast agent. |
| Q57355693 | A predictive model of iron oxide nanoparticles flocculation tuning Z-potential in aqueous environment for biological application |
| Q30774704 | A quantitative relaxometric version of the ELISA test for the measurement of cell surface biomarkers |
| Q42097453 | A versatile and tunable coating strategy allows control of nanocrystal delivery to cell types in the liver |
| Q33654373 | Accelerated stem cell labeling with ferucarbotran and protamine |
| Q55462364 | Adiabatic pulse preparation for imaging iron oxide nanoparticles. |
| Q26782710 | Advanced cell therapies: targeting, tracking and actuation of cells with magnetic particles |
| Q26863117 | Advances in using MRI probes and sensors for in vivo cell tracking as applied to regenerative medicine |
| Q30808499 | Alginate-coated magnetic nanoparticles for noninvasive MRI of extracellular calcium. |
| Q93074167 | Alternating-Magnetic-Field-Mediated Wireless Manipulations of a Liquid Metal for Therapeutic Bioengineering |
| Q36443368 | Analysis of Lanthanide Complex Dendrimer Conjugates for Bimodal NIR and MRI Imaging |
| Q51495278 | Analysis of polyvinyl alcohol microbubbles in human blood plasma using capillary electrophoresis. |
| Q36543499 | Anti-αvβ3 antibody guided three-step pretargeting approach using magnetoliposomes for molecular magnetic resonance imaging of breast cancer angiogenesis |
| Q30423880 | Antibody-based imaging of HER-2: moving into the clinic. |
| Q48883655 | Application of MRI phase-difference mapping to assessment of vascular concentrations of BMS agent in mice. |
| Q41360994 | Application of magnetic resonance imaging for monitoring stem cell transplantation for the treatment of cerebral ischemia |
| Q40190895 | Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. |
| Q44629222 | Assessment of inflammation with a very small iron-oxide particle in a murine model of reperfused myocardial infarction |
| Q27002379 | Assessment of multifunctional contrast agent probes in neuroimaging: Implications of nanopharmaceutical therapeutic interventions |
| Q41540394 | Autonomous magnetic labelling of functional mesenchymal stem cells for improved traceability and spatial control in cell therapy applications. |
| Q90151923 | Bacteriogenic magnetic nanoparticles as magnetic resonance imaging contrast agents |
| Q37362981 | Behavior of immune players in the tumor microenvironment |
| Q33564661 | Bifunctional Eu(3+)-doped Gd(2)O(3) nanoparticles as a luminescent and T(1) contrast agent for stem cell labeling |
| Q33654922 | Bifunctional Gold Nanoshells with a Superparamagnetic Iron Oxide-Silica Core Suitable for Both MR Imaging and Photothermal Therapy. |
| Q53084368 | Biocompatible and high-performance amino acids-capped MnWO4 nanocasting as a novel non-lanthanide contrast agent for X-ray computed tomography and T(1)-weighted magnetic resonance imaging. |
| Q27025163 | Biodegradable, polymer encapsulated, metal oxide particles for MRI-based cell tracking |
| Q37278614 | Biodistribution of newly synthesized PHEA-based polymer-coated SPION in Sprague Dawley rats as magnetic resonance contrast agent |
| Q35048175 | Biologically optimized nanosized molecules and particles: more than just size |
| Q56911559 | CCVD Synthesis of Carbon-Encapsulated Cobalt Nanoparticles for Biomedical Applications |
| Q35075432 | Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin |
| Q54339513 | Can magnetic targeting of magnetically labeled circulating cells optimize intramyocardial cell retention? |
| Q38288055 | Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking |
| Q33831404 | Carbon-covered magnetic nanomaterials and their application for the thermolysis of cancer cells |
| Q36823807 | Cardiovascular molecular MR imaging |
| Q37441802 | Cell labeling and tracking for experimental models using magnetic resonance imaging |
| Q39687176 | Cell labeling with a novel contrast agent of magnetic resonance imaging. |
| Q43862932 | Cell labeling with the positive MR contrast agent Gadofluorine M. |
| Q37174473 | Cell tracking with optical imaging |
| Q36277263 | Cell-based therapies and imaging in cardiology |
| Q37096959 | Cellular MRI and its role in stem cell therapy |
| Q45305523 | Cellular MRI as a suitable, sensitive non-invasive modality for correlating in vivo migratory efficiencies of different dendritic cell populations with subsequent immunological outcomes |
| Q36485270 | Cellular magnetic resonance imaging: in vivo imaging of melanoma cells in lymph nodes of mice |
| Q37209833 | Cellular magnetic resonance imaging: potential for use in assessing aspects of cardiovascular disease |
| Q39556343 | Cellular uptake and imaging studies of gadolinium-loaded single-walled carbon nanotubes as MRI contrast agents. |
| Q64901274 | Characterization of Magnetic Nanoparticle-Seeded Microspheres for Magnetomotive and Multimodal Imaging. |
| Q50544093 | Characterization of the inflammatory response in a photothrombotic stroke model by MRI: implications for stem cell transplantation. |
| Q52991518 | Chelator free gallium-68 radiolabelling of silica coated iron oxide nanorods via surface interactions. |
| Q38111394 | Chemical Exchange Saturation Transfer (CEST) Imaging: Description of Technique and Potential Clinical Applications |
| Q34560453 | Cleaved iron oxide nanoparticles as T2 contrast agents for magnetic resonance imaging |
| Q35903264 | Clinically applicable magnetic-labeling of natural killer cells for MRI of transcatheter delivery to liver tumors: preclinical validation for clinical translation |
| Q35106957 | Clinically viable magnetic poly(lactide-co-glycolide) particles for MRI-based cell tracking. |
| Q33979101 | Clodronate-superparamagnetic iron oxide-containing liposomes attenuate renal injury in rats with severe acute pancreatitis |
| Q39805266 | Comparison of superparamagnetic and ultrasmall superparamagnetic iron oxide cell labeling for tracking green fluorescent protein gene marker with negative and positive contrast magnetic resonance imaging |
| Q36714422 | Conjugation to Biocompatible Dendrimers Increases Lanthanide T2 Relaxivity of Hydroxypyridinone (HOPO) Complexes for Magnetic Resonance Imaging (MRI) |
| Q37456312 | Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo |
| Q30428858 | Contrast-enhanced magneto-photo-acoustic imaging in vivo using dual-contrast nanoparticles |
| Q33888993 | Contribution of macrophages in the contrast loss in iron oxide-based MRI cancer cell tracking studies |
| Q38853697 | Core/shell Fe3O4/Gd2O3 nanocubes as T1-T2 dual modal MRI contrast agents. |
| Q51247404 | Coupled cellular therapy and magnetic targeting for airway regeneration. |
| Q38497007 | Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. |
| Q46738511 | Cryopreservation of embryonic stem cell-derived multicellular neural aggregates labeled with micron-sized particles of iron oxide for magnetic resonance imaging |
| Q50034205 | Current Application of Capillary Electrophoresis in Nanomaterial Characterisation and Its Potential to Characterise the Protein and Small Molecule Corona |
| Q28078431 | Current Concept of Stem Cell Therapy for Spinal Cord Injury: A Review |
| Q38545834 | Current Perspectives in Mesenchymal Stromal Cell Therapies for Airway Tissue Defects |
| Q53526639 | Current status of imaging pancreatic islets. |
| Q91779530 | D-mannose-Coating of Maghemite Nanoparticles Improved Labeling of Neural Stem Cells and Allowed Their Visualization by ex vivo MRI after Transplantation in the Mouse Brain |
| Q37212802 | Dendritic cell vaccination and immune monitoring. |
| Q47294345 | Dendron-Grafted Polylysine-Based Dual-Modal Nanoprobe for Ultra-Early Diagnosis of Pancreatic Precancerosis via Targeting a Urokinase-Type Plasminogen Activator Receptor. |
| Q39647341 | Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging |
| Q28830216 | Design and pharmacokinetical aspects for the use of inorganic nanoparticles in radiomedicine |
| Q34603392 | Design maps for the hyperthermic treatment of tumors with superparamagnetic nanoparticles |
| Q28283802 | Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers |
| Q46926167 | Designing feedback-based contrast enhancement for in vivo imaging |
| Q37189031 | Detection and quantification of magnetically labeled cells by cellular MRI |
| Q35609635 | Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI |
| Q30678695 | Developing Fe3O4 nanoparticles into an efficient multimodality imaging and therapeutic probe. |
| Q37879476 | Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI. |
| Q30620922 | Development of PEGylated KMnF3 nanoparticles as a T1-weighted contrast agent: chemical synthesis, in vivo brain MR imaging, and accounting for high relaxivity |
| Q34069767 | Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging |
| Q39769028 | Development of a three-dimensional in vitro model for longitudinal observation of cell behavior: monitoring by magnetic resonance imaging and optical imaging |
| Q33877509 | Development of iron-containing multiwalled carbon nanotubes for MR-guided laser-induced thermotherapy. |
| Q34609644 | Dextran coated bismuth-iron oxide nanohybrid contrast agents for computed tomography and magnetic resonance imaging |
| Q35809585 | Different effect of hydrogelation on antifouling and circulation properties of dextran-iron oxide nanoparticles |
| Q37471523 | Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance |
| Q50444289 | Direct labeling of hMSC with SPIO: the long-term influence on toxicity, chondrogenic differentiation capacity, and intracellular distribution. |
| Q31077545 | Direct quantitative 13 C-filtered 1 H magnetic resonance imaging of PEGylated biomacromolecules in vivo. |
| Q45883783 | Discrepancies between the fate of myoblast xenograft in mouse leg muscle and NMR label persistency after loading with Gd-DTPA or SPIOs |
| Q36776839 | Dual contrast agent for computed tomography and magnetic resonance hard tissue imaging |
| Q42825888 | Dual-modality, dual-functional nanoprobes for cellular and molecular imaging. |
| Q34447715 | Dynamics of Magnetic Nanoparticle-Based Contrast Agents in Tissues Tracked Using Magnetomotive Optical Coherence Tomography |
| Q39677767 | EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma |
| Q79738406 | Effect of concentration of SH U 555A labeled human melanoma cells on MR spin echo and gradient echo signal decay at 0.2, 1.5, and 3T |
| Q82520600 | Effect of spatial distribution of magnetic dipoles on Lamor frequency distribution and MR Signal decay--a numerical approach under static dephasing conditions |
| Q42715190 | Effects of DMSA-coated Fe3O4 nanoparticles on the transcription of genes related to iron and osmosis homeostasis |
| Q56777725 | Effects of MRI Contrast Agents on the Stem Cell Phenotype |
| Q91874284 | Effects of Metal Oxide Nanoparticles on Toll-Like Receptor mRNAs in Human Monocytes |
| Q35605942 | Effects of PVA coated nanoparticles on human immune cells |
| Q36762963 | Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. |
| Q34331534 | Effects of iron oxide nanoparticle labeling on human endothelial cells |
| Q40899589 | Effects of iron oxide nanoparticles on biological responses and MR imaging properties in human mammary healthy and breast cancer epithelial cells |
| Q59132576 | Effects of labeling human mesenchymal stem cells with superparamagnetic iron oxides on cellular functions and magnetic resonance contrast in hypoxic environments and long-term monitoring |
| Q39920573 | Efficient cellular labeling by CD44 receptor-mediated uptake of cationic liposomes functionalized with hyaluronic acid and loaded with MRI contrast agents. |
| Q40003333 | Efficient stem cell labeling for MRI studies. |
| Q30937038 | Elimination of iron-containing magnetic nanoparticles from the site of injection in mice: a magnetic-resonance imaging study. |
| Q39029771 | Encapsulated gadolinium and dysprosium ions within ultra-short carbon nanotubes for MR microscopy at 11.75 and 21.1 T. |
| Q39648404 | Engineered biocompatible nanoparticles for in vivo imaging applications. |
| Q37895953 | Engineered nanoparticles for biomolecular imaging |
| Q58120574 | Engineering molecular imaging strategies for regenerative medicine |
| Q34216577 | Engineering novel detectors and sensors for MRI |
| Q31117230 | Enhanced diffusion weighting generated by selective adiabatic pulse trains. |
| Q37440240 | Enhanced positive-contrast visualization of paramagnetic contrast agents using phase images |
| Q47955808 | Enzyme-Responsive LipoCEST Agents: Assessment of MMP-2 Activity by Measuring the Intra-liposomal Water 1 H NMR Shift. |
| Q30743835 | Epicardium-Derived Cells Formed After Myocardial Injury Display Phagocytic Activity Permitting In Vivo Labeling and Tracking |
| Q42062783 | Epitaxially stabilized thin films of ε-Fe2O3 (001) grown on YSZ (100). |
| Q39586854 | Evaluation of the specificity and sensitivity of ferritin as an MRI reporter gene in the mouse brain using lentiviral and adeno-associated viral vectors. |
| Q44964482 | Ex vivo magnetic resonance imaging of transplanted hepatocytes in a rat model of acute liver failure |
| Q39968080 | Ex-vivo cellular MRI with b-SSFP: quantitative benefits of 3T over 1.5 T. |
| Q37906480 | Exploiting the tumor microenvironment for theranostic imaging |
| Q41865534 | Exposure to Iron Oxide Nanoparticles Coated with Phospholipid-Based Polymeric Micelles Induces Biochemical and Histopathological Pulmonary Changes in Mice |
| Q42079813 | Feasibility of concurrent dual contrast enhancement using CEST contrast agents and superparamagnetic iron oxide particles |
| Q90298857 | Feraheme (Ferumoxytol) Is Recognized by Proinflammatory and Anti-inflammatory Macrophages via Scavenger Receptor Type AI/II |
| Q40313711 | Ferritin heavy chain as a molecular imaging reporter gene in glioma xenografts |
| Q90455847 | Ferritin-EGFP Chimera as an Endogenous Dual-Reporter for Both Fluorescence and Magnetic Resonance Imaging in Human Glioma U251 Cells |
| Q33740276 | Fluorescence-enhanced gadolinium-doped zinc oxide quantum dots for magnetic resonance and fluorescence imaging |
| Q35024242 | Fluorescent magnetic iron oxide nanoparticles for cardiac precursor cell selection from stromal vascular fraction and optimization for magnetic resonance imaging |
| Q34635770 | Fluorine (19F) MRS and MRI in biomedicine |
| Q39912198 | Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking |
| Q48856993 | Functional characterization of mesenchymal stem cells labeled with a novel PVP-coated superparamagnetic iron oxide |
| Q31067306 | Functional nanoparticles for magnetic resonance imaging |
| Q48229636 | Gadolinium hybrid iron oxide nanocomposites for dual T1- and T2-weighted MR imaging of cell labeling |
| Q39022721 | Gadolinium-enriched polyaniline particles (GPAPs) for simultaneous diagnostic imaging and localized photothermal therapy of epithelial cancer. |
| Q88447232 | Gas vesicles as collapsible MRI contrast agents |
| Q30724674 | Gd loading by hypotonic swelling: an efficient and safe route for cellular labeling |
| Q38480924 | Gd-EOB-DTPA Enhanced Micro-MR Imaging of Hepatic Tumors in H-ras 12V Transgenic Mice |
| Q33806301 | Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles |
| Q30485161 | Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease |
| Q39813598 | HDL as a contrast agent for medical imaging |
| Q86895637 | Hepatocyte transplantation |
| Q33429230 | High-relaxivity gadolinium-modified high-density lipoproteins as magnetic resonance imaging contrast agents |
| Q36408332 | High-relaxivity superparamagnetic iron oxide nanoworms with decreased immune recognition and long-circulating properties |
| Q36007145 | Highly sensitive magnetite nano clusters for MR cell imaging |
| Q37724582 | Human hepatocyte transplantation: current experience and future challenges. |
| Q36743711 | Human serum albumin coated iron oxide nanoparticles for efficient cell labeling |
| Q57377086 | Hybrid lanthanide nanoparticles as a new class of binary contrast agents for in vivo T1/T2 dual-weighted MRI and synergistic tumor diagnosis |
| Q41835678 | Hydrophilic Monodisperse Magnetic Nanoparticles Protected by an Amphiphilic Alternating Copolymer |
| Q41680635 | Hydrophilization of Magnetic Nanoparticles with Modified Alternating Copolymers. Part 1: The Influence of the Grafting |
| Q33760563 | Imaging approaches for the study of cell-based cardiac therapies |
| Q37871466 | Imaging cardiac stem cell therapy: translations to human clinical studies |
| Q37398307 | Imaging of primary human hepatocytes performed with micron-sized iron oxide particles and clinical magnetic resonance tomography. |
| Q37103706 | Imaging of stem cells using MRI. |
| Q50666246 | Imaging stem cell therapy for the treatment of peripheral arterial disease. |
| Q36017919 | Imaging transplanted stem cells in real time using an MRI dual-contrast method |
| Q42417127 | Impact of surface coating and particle size on the uptake of small and ultrasmall superparamagnetic iron oxide nanoparticles by macrophages |
| Q35642484 | Improved quantitative (19) F MR molecular imaging with flip angle calibration and B1 -mapping compensation |
| Q35687164 | Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticles |
| Q30559846 | In situ labeling and imaging of endogenous neural stem cell proliferation and migration |
| Q34478533 | In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI. |
| Q38910497 | In vitro cytotoxicity analysis of doxorubicin-loaded/superparamagnetic iron oxide colloidal nanoassemblies on MCF7 and NIH3T3 cell lines |
| Q46647247 | In vitro imaging of single living human umbilical vein endothelial cells with a clinical 3.0-T MRI scanner |
| Q54057673 | In vitro sustained release study of gallic acid coated with magnetite-PEG and magnetite-PVA for drug delivery system. |
| Q39913556 | In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles |
| Q37166732 | In vivo MR imaging of magnetically labeled mesenchymal stem cells in a rat model of renal ischemia |
| Q37483678 | In vivo MRI cell tracking using perfluorocarbon probes and fluorine-19 detection |
| Q33803809 | In vivo MRI cell tracking: clinical studies |
| Q48401147 | In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain |
| Q34550853 | In vivo MRI tracking of cell invasion and migration in a rat glioma model |
| Q37391276 | In vivo cytometry of antigen-specific t cells using 19F MRI |
| Q47243507 | In vivo identification of sentinel lymph nodes using MRI and size-controlled and monodispersed magnetite nanoparticles |
| Q37822291 | In vivo imaging of immune cell trafficking in cancer |
| Q35842510 | In vivo imaging of macrophages during the early-stages of abdominal aortic aneurysm using high resolution MRI in ApoE mice |
| Q37440349 | In vivo imaging of stem cells and Beta cells using direct cell labeling and reporter gene methods |
| Q34109958 | In vivo imaging of stepwise vessel occlusion in cerebral photothrombosis of mice by 19F MRI. |
| Q36488762 | In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease |
| Q48828850 | In vivo labelling of resting monocytes in the reticuloendothelial system with fluorescent iron oxide nanoparticles prior to injury reveals that they are mobilized to infarcted myocardium |
| Q48901575 | In vivo leukocyte labeling with intravenous ferumoxides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging |
| Q30454393 | In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. |
| Q34698260 | In vivo magnetic resonance imaging and optical imaging comparison of viable and nonviable mesenchymal stem cells with a bifunctional label |
| Q41768523 | In vivo magnetic resonance imaging of amyloid-β plaques in mice |
| Q50744987 | In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice. |
| Q34540793 | In vivo magnetic resonance imaging tracking of transplanted superparamagnetic iron oxide-labeled bone marrow mesenchymal stem cells in rats with myocardial infarction |
| Q30478802 | In vivo magnetomotive optical molecular imaging using targeted magnetic nanoprobes |
| Q37157569 | In vivo molecular imaging of vascular stress |
| Q36373902 | In vivo molecular imaging using nanomaterials: general in vivo characteristics of nano-sized reagents and applications for cancer diagnosis |
| Q39384901 | In vivo multicolor molecular MR imaging using diamagnetic chemical exchange saturation transfer liposomes |
| Q33652225 | In vivo off-resonance saturation magnetic resonance imaging of alphavbeta3-targeted superparamagnetic nanoparticles |
| Q83348528 | In vivo tracking of cellular therapeutics using magnetic resonance imaging |
| Q31118065 | In vivo tracking of stem cells in brain and spinal cord injury |
| Q38917592 | In vivo visualization and ex vivo quantification of murine breast cancer cells in the mouse brain using MRI cell tracking and electron paramagnetic resonance. |
| Q53080708 | In vivo visualization of cells labeled with superparamagnetic iron oxides by a sub-millisecond gradient echo sequence. |
| Q27339181 | In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery |
| Q37668307 | In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging |
| Q57186144 | In vivo visualization of transplanted pancreatic islets by MRI: comparison between in vivo, histological and electron microscopy findings |
| Q61612309 | Indium-111 oxine labelling affects the cellular integrity of haematopoietic progenitor cells |
| Q30585395 | Inorganic nanocrystals as contrast agents in MRI: synthesis, coating and introduction of multifunctionality |
| Q30564493 | Inorganic nanoparticle-based T1 and T1/T2 magnetic resonance contrast probes |
| Q40237616 | Internal structure of magnetic endosomes |
| Q39376156 | Intracellular SPIO labeling of microglia: high field considerations and limitations for MR microscopy. |
| Q34974118 | Investigation of In Vivo Targeting Kinetics of α(v)β(3)-Specific Superparamagnetic Nanoprobes by Time-Resolved MRI. |
| Q26781657 | Iron Oxide as an MRI Contrast Agent for Cell Tracking |
| Q42057585 | Iron Oxide-labeled Collagen Scaffolds for Non-invasive MR Imaging in Tissue Engineering. |
| Q33506902 | Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging |
| Q34379425 | Iron oxide nanoparticle-based magnetic resonance method to monitor release kinetics from polymeric particles with high resolution |
| Q35974687 | Labeling Human Melanoma Cells With SPIO: In Vitro Observations |
| Q91687333 | Labeling Stem Cells with a New Hybrid Bismuth/Carbon Nanotube Contrast Agent for X-Ray Imaging |
| Q37127713 | Labeling of stem cells with monocrystalline iron oxide for tracking and localization by magnetic resonance imaging |
| Q50687532 | Labeling protocols for in vivo tracking of human skeletal muscle cells (HSkMCs) by magnetic resonance and bioluminescence imaging. |
| Q48152686 | Lentiviral transduction and subsequent loading with nanoparticles do not affect cell viability and proliferation in hair-follicle-bulge-derived stem cells in vitro. |
| Q42112459 | Linking Hydrophilic Macromolecules to Monodisperse Magnetite (Fe(3)O(4)) Nanoparticles via Trichloro-s-triazine |
| Q43098424 | Liver and brain imaging through dimercaptosuccinic acid-coated iron oxide nanoparticles |
| Q34182540 | Longitudinal tracking of human fetal cells labeled with super paramagnetic iron oxide nanoparticles in the brain of mice with motor neuron disease |
| Q47412727 | Low molecular weight alkyl-polycation wrapped magnetite nanoparticle clusters as MRI probes for stem cell labeling and in vivo imaging |
| Q42280759 | MPI Cell Tracking: What Can We Learn from MRI? |
| Q34515707 | MR imaging features of gadofluorine-labeled matrix-associated stem cell implants in cartilage defects |
| Q48822800 | MR imaging for the longevity of mesenchymal stem cells labeled with poly-L-lysine-Resovist complexes. |
| Q42105676 | MR imaging of transplanted stem cells in myocardial infarction |
| Q36953715 | MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles |
| Q36754201 | MR-based imaging of neural stem cells |
| Q33701395 | MR-based molecular imaging of the brain: the next frontier. |
| Q57258891 | MRI Contrast Agents Based on Inorganic Nanoparticles |
| Q37054230 | MRI in ocular drug delivery. |
| Q33806015 | MRI in rodent models of brain disorders |
| Q39342217 | MRI of prostate stem cell antigen expression in prostate tumors |
| Q30578470 | MRI tracking of macrophages labeled with glucan particles entrapping a water insoluble paramagnetic Gd-based agent |
| Q44074421 | MRI tracking of transplanted iron-labeled mesenchymal stromal cells in an immune-compromised mouse model of critical limb ischemia. |
| Q34325715 | MRl of prostate cancer antigen expression for diagnosis and immunotherapy |
| Q35559728 | MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter. |
| Q92108247 | Magnetic Manipulation of Blood Conductivity with Superparamagnetic Iron Oxide-Loaded Erythrocytes |
| Q48654075 | Magnetic Nanoparticles Labeled Mesenchymal Stem Cells: A Pragmatic Solution toward Targeted Cancer Theranostics |
| Q41220555 | Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging. |
| Q90497407 | Magnetic Nanoparticles in Cancer Therapy and Diagnosis |
| Q30696266 | Magnetic Resonance Imaging of Iron Oxide-Labeled Human Embryonic Stem Cell-Derived Cardiac Progenitors |
| Q36918024 | Magnetic and fluorescent nanoparticles for multimodality imaging. |
| Q90275104 | Magnetic core-shell nanowires as MRI contrast agents for cell tracking |
| Q38150882 | Magnetic fluid hyperthermia: advances, challenges, and opportunity. |
| Q33852478 | Magnetic iron oxide nanoparticles for biomedical applications |
| Q50455581 | Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study. |
| Q37855910 | Magnetic labeling, imaging and manipulation of endothelial progenitor cells using iron oxide nanoparticles |
| Q33374556 | Magnetic nanoparticle imaging by means of minimum norm estimates from remanence measurements |
| Q36917874 | Magnetic nanoparticles and their applications in medicine |
| Q37978479 | Magnetic nanoparticles for cancer diagnosis and therapy |
| Q37192908 | Magnetic nanoparticles in MR imaging and drug delivery. |
| Q37375294 | Magnetic nanoparticles: surface effects and properties related to biomedicine applications |
| Q37668366 | Magnetic quantum dots for multimodal imaging |
| Q31058941 | Magnetic resonance imaging and cell-based neurorestorative therapy after brain injury. |
| Q36861531 | Magnetic resonance imaging and fluorescence labeling of clinical-grade mesenchymal stem cells without impacting their phenotype: study in a rat model of stroke |
| Q89345815 | Magnetic resonance imaging contrast enhancement in vitro and in vivo by octanuclear iron-oxo cluster-based agents |
| Q31124447 | Magnetic resonance imaging in animal models of epilepsy-noninvasive detection of structural alterations |
| Q42726387 | Magnetic resonance imaging of cells in experimental disease models |
| Q39539318 | Magnetic resonance imaging of human dental pulp stem cells in vitro and in vivo. |
| Q40192206 | Magnetic resonance imaging of iron-oxide labeled SK-Mel 28 human melanoma cells in the chick embryo using a clinical whole body MRI scanner |
| Q39445337 | Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles |
| Q42109077 | Magnetic resonance imaging of monocytes labeled with ultrasmall superparamagnetic particles of iron oxide using magnetoelectroporation in an animal model of multiple sclerosis. |
| Q33670273 | Magnetic resonance imaging of the migration of neuronal precursors generated in the adult rodent brain |
| Q50688699 | Magnetic resonance imaging probes for labeling of chondrocyte cells. |
| Q48704444 | Magnetic resonance imaging tracking of ultra small superparamagnetic iron oxide labeled rabbit dendritic cells |
| Q33716206 | Magnetic resonance imaging, microscopy, and spectroscopy of the central nervous system in experimental animals |
| Q38842822 | Magnetic resonance relaxation induced by superparamagnetic particles used as contrast agents in magnetic resonance imaging: a theoretical review. |
| Q33521948 | Magnetic resonance relaxation properties of superparamagnetic particles |
| Q38005988 | Magnetic resonance reporter gene imaging |
| Q48943581 | Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy |
| Q51050921 | Magnetic separation of proteins by a self-assembled supramolecular ternary complex. |
| Q39896527 | Magnetic targeting of iron-oxide-labeled fluorescent hepatoma cells to the liver |
| Q37617371 | Magnetically modulated nanosystems: a unique drug-delivery platform |
| Q59019933 | Magnetization and Specific Absorption Rate Studies of Ball-Milled Iron Oxide Nanoparticles for Biomedicine |
| Q41774666 | Magnetization transfer contrast MRI for non-invasive assessment of innate and adaptive immune responses against alginate-encapsulated cells |
| Q30359959 | Magneto acoustic tomography with short pulsed magnetic field for in-vivo imaging of magnetic iron oxide nanoparticles |
| Q53513254 | Magneto-plasmonic nanoparticles as theranostic platforms for magnetic resonance imaging, drug delivery and NIR hyperthermia applications. |
| Q30459417 | Magnetoacoustic imaging of magnetic iron oxide nanoparticles embedded in biological tissues with microsecond magnetic stimulation |
| Q93357565 | Magnetocaloric materials as switchable high contrast ratio MRI labels |
| Q37871989 | Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics |
| Q98204535 | Magnetomotive Ultrasound Imaging Systems: Basic Principles and First Applications |
| Q34544058 | Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes |
| Q38657496 | Main applications of hybrid PET-MRI contrast agents: a review. |
| Q36872867 | Manganese dioxide nanosheets-based redox/pH-responsive drug delivery system for cancer theranostic application |
| Q30687386 | Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies. |
| Q30442598 | Markers of cochlear inflammation using MRI. |
| Q33480124 | Measuring SPIO and Gd contrast agent magnetization using 3 T MRI. |
| Q31032909 | Mechanism of cellular uptake and impact of ferucarbotran on macrophage physiology |
| Q43043648 | Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum |
| Q81478203 | Medical imaging: Colourful future for MRI |
| Q39982412 | Mesenchymal stem cell labeling and in vitro MR characterization at 1.5 T of new SPIO contrast agent: Molday ION Rhodamine-B™. |
| Q34992017 | Mesenchymal stem cell tracking in the intervertebral disc |
| Q27003059 | Mesenchymal stem cells migration homing and tracking |
| Q34575909 | Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist--an initial in vitro study. |
| Q57258860 | Mesoporous silica-coated luminescent Eu3+doped GdVO4nanoparticles for multimodal imaging and drug delivery |
| Q33385928 | Metabolomics of neural progenitor cells: a novel approach to biomarker discovery |
| Q57962541 | Metal Oxide Nanoparticles |
| Q91975666 | Metal Oxysulfides: From Bulk Compounds to Nanomaterials |
| Q34731187 | Microfabricated high‐moment micrometer‐sized MRI contrast agents |
| Q40069509 | Migration of neurotrophic factors-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imaging. |
| Q28608079 | Modelling mass and heat transfer in nano-based cancer hyperthermia |
| Q39017220 | Modification of the surface of superparamagnetic iron oxide nanoparticles to enable their safe application in humans |
| Q37629944 | Modified natural nanoparticles as contrast agents for medical imaging. |
| Q30463697 | Molecular Imaging Probe Development using Microfluidics. |
| Q33734761 | Molecular MRI for sensitive and specific detection of lung metastases |
| Q37162995 | Molecular MRI of hematopoietic stem-progenitor cells: in vivo monitoring of gene therapy and atherosclerosis |
| Q36853933 | Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium |
| Q30612000 | Molecular imaging of cancer cells using a bacteriophage-based 129Xe NMR biosensor |
| Q36416525 | Molecular imaging of cardiac stem cell transplantation |
| Q34805318 | Molecular imaging of induced pluripotent stem cell immunogenicity with in vivo development in ischemic myocardium |
| Q34834164 | Molecular imaging of influenza and other emerging respiratory viral infections. |
| Q33917943 | Molecular imaging of metastatic potential |
| Q38003151 | Molecular imaging of stem cells: tracking survival, biodistribution, tumorigenicity, and immunogenicity |
| Q36680209 | Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with (64)Cu-DOTA-trastuzumab |
| Q30362056 | Monitoring/Imaging and Regenerative Agents for Enhancing Tissue Engineering Characterization and Therapies |
| Q41897844 | Monodisperse magnetite nanoparticles coupled with nuclear localization signal peptide for cell-nucleus targeting |
| Q92936943 | Morphological Evolution of Gold Nanoparticles into Nanodendrites Using Catechol-Grafted Polymer Templates |
| Q30987781 | Multi-chromatic magnetic resonance imaging using frequency lock-in suppression |
| Q33946006 | Multifunctional Magnetic Nanoparticles for Medical Imaging Applications |
| Q35610814 | Multifunctional Nd(3+)-sensitized upconversion nanomaterials for synchronous tumor diagnosis and treatment |
| Q30785098 | Multifunctional PEGylated multiwalled carbon nanotubes for enhanced blood pool and tumor MR imaging |
| Q41095433 | Multifunctional Particles: Magnetic Nanocrystals and Gold Nanorods Coated with Fluorescent Dye-Doped Silica Shells |
| Q37360440 | Multifunctional SPIO/DOX-loaded A54 Homing Peptide Functionalized Dextran-g-PLGA Micelles for Tumor Therapy and MR Imaging |
| Q34781329 | Multifunctional capsule-in-capsules for immunoprotection and trimodal imaging |
| Q37663915 | Multifunctional imaging nanoprobes |
| Q51735768 | Multifunctional nanomedicine with silica: Role of silica in nanoparticles for theranostic, imaging, and drug monitoring. |
| Q37564506 | Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy |
| Q37377524 | Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. |
| Q34504759 | Multifunctional uniform core-shell Fe3O4@mSiO2 mesoporous nanoparticles for bimodal imaging and photothermal therapy. |
| Q39024385 | Multimodal cell tracking of a spontaneous metastasis model: comparison between MRI, electron paramagnetic resonance and bioluminescence. |
| Q37222159 | Multimodality nanotracers for cardiovascular applications. |
| Q26740054 | Multiwalled carbon nanotube hybrids as MRI contrast agents |
| Q53253206 | NMR relaxation and magnetic properties of superparamagnetic nanoworms. |
| Q37977128 | Nano-regenerative medicine towards clinical outcome of stem cell and tissue engineering in humans. |
| Q34218174 | Nanoclusters of iron oxide: effect of core composition on structure, biocompatibility, and cell labeling efficacy |
| Q37069877 | Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform |
| Q81697970 | Nanomagnetic actuation of receptor-mediated signal transduction |
| Q26863316 | Nanoparticle contrast agents for computed tomography: a focus on micelles |
| Q47442352 | Nanoparticle-Based Therapeutics for Brain Injury |
| Q26824262 | Nanoparticle-based systems for T(1)-weighted magnetic resonance imaging contrast agents |
| Q36514508 | Nanoparticles and clinically applicable cell tracking. |
| Q37397058 | Nanoparticles and their applications in cell and molecular biology |
| Q30354652 | Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer. |
| Q37799541 | Nanoparticles for cell labeling |
| Q37835203 | Nanoparticles in biological systems |
| Q28082690 | Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents |
| Q42149450 | Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging |
| Q48163734 | Nanoscale Metal-Organic Frameworks Decorated with Graphene Oxide for Magnetic Resonance Imaging Guided Photothermal Therapy |
| Q28307795 | Nanotechnology and MRI contrast enhancement |
| Q37240998 | Nanotechnology for regenerative medicine: nanomaterials for stem cell imaging |
| Q87354367 | Negatively charged superparamagnetic iron oxide nanoparticles: a new blood-pooling magnetic resonance contrast agent |
| Q38094240 | New frontiers and developing applications in 19F NMR. |
| Q28534906 | New strategies to prolong the in vivo life span of iron-based contrast agents for MRI |
| Q38767343 | Non-Temperature Induced Effects of Magnetized Iron Oxide Nanoparticles in Alternating Magnetic Field in Cancer Cells. |
| Q37148295 | Non-invasive tracking of CD4+ T cells with a paramagnetic and fluorescent nanoparticle in brain ischemia |
| Q35052184 | Noninvasive MRI of endothelial cell response to human breast cancer cells. |
| Q34807017 | Noninvasive MRI-SERS imaging in living mice using an innately bimodal nanomaterial |
| Q30481557 | Noninvasive cardiovascular imaging techniques for basic science research: application to cellular therapeutics |
| Q40300829 | Noninvasive evaluation of immunosuppressive drug efficacy on acute donor cell survival |
| Q89289978 | Noninvasive imaging of nanoparticle-labeled transplant populations within polymer matrices for neural cell therapy |
| Q33643871 | Noninvasive monitoring of embryonic stem cells in vivo with MRI transgene reporter |
| Q92945844 | Novel Biocompatible and Biodegradable PCL-PLA/ Iron Oxide NPs Marker Clip Composite for Breast Cancer Biopsy |
| Q30318148 | Novel aqueous nano-scaled formulations of oleic acid stabilized hydrophobic superparamagnetic iron oxide nanocrystals |
| Q34443753 | Novel positively charged nanoparticle labeling for in vivo imaging of adipose tissue-derived stem cells |
| Q51794138 | Octapod iron oxide nanoparticles as high-performance T₂ contrast agents for magnetic resonance imaging. |
| Q34610010 | Off-resonance saturation MRI of superparamagnetic nanoprobes: theoretical models and experimental validations |
| Q33517367 | Off-resonance saturation magnetic resonance imaging of superparamagnetic polymeric micelles. |
| Q64967078 | Optimization of molecularly targeted MRI in the brain: empirical comparison of sequences and particles. |
| Q36571199 | Overview of stem cells and imaging modalities for cardiovascular diseases |
| Q38741159 | PEG coating reduces NMR relaxivity of Mn(0.5)Zn(0.5)Gd(0.02)Fe(1.98)O4 hyperthermia nanoparticles. |
| Q33693590 | PEG-Functionalized Magnetic Nanoparticles for Drug Delivery and Magnetic Resonance Imaging Applications |
| Q42088681 | PEGylated silica-enzyme nanoconjugates: a new frontier in large scale separation of α-amylase |
| Q47951991 | PET-based imaging to detect and characterize cardiovascular disorders: Unavoidable path for the foreseeable future |
| Q45848579 | Paramagnetic inorganic nanoparticles as T1 MRI contrast agents |
| Q39911952 | Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging |
| Q34334874 | Paramagnetic nanoparticles as potential MRI contrast agents: characterization, NMR relaxation, simulations and theory |
| Q38168208 | Patient-specific computational modeling and magnetic nanoconstructs: tools for maximizing the efficacy of stem cell-based therapies. |
| Q58677630 | Peptide functionalized superparamagnetic iron oxide nanoparticles as MRI contrast agents |
| Q36335838 | Personalized nanomedicine advancements for stem cell tracking. |
| Q38707035 | Phosphatidylserine-Targeted Nanotheranostics for Brain Tumor Imaging and Therapeutic Potential |
| Q42363680 | Phosphatidylserine-targeted liposome for enhanced glioma-selective imaging |
| Q36428190 | Poly (dopamine) coated superparamagnetic iron oxide nanocluster for noninvasive labeling, tracking, and targeted delivery of adipose tissue-derived stem cells. |
| Q34251189 | Polymersome magneto-valves for reversible capture and release of nanoparticles |
| Q31004643 | Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents |
| Q48699040 | Positive contrast of SPIO-labeled cells by off-resonant reconstruction of 3D radial half-echo bSSFP. |
| Q55463789 | Positive contrast technique for the detection and quantification of superparamagnetic iron oxide nanoparticles in MRI. |
| Q35172238 | Positive contrast with alternating repetition time SSFP (PARTS): a fast imaging technique for SPIO-labeled cells |
| Q51766811 | Potential use of superparamagnetic iron oxide nanoparticles for in vitro and in vivo bioimaging of human myoblasts. |
| Q26995358 | Pre- and postmortem imaging of transplanted cells |
| Q36240694 | Preclinical evaluation of a urokinase plasminogen activator receptor-targeted nanoprobe in rhesus monkeys |
| Q64969235 | Preparation and Characterization of a New Low Refractive Index Ferrofluid. |
| Q53314967 | Preparation of magnetite-chitosan/methylcellulose nanospheres by entrapment and adsorption techniques for targeting the anti-cancer drug 5-fluorouracil. |
| Q33908288 | Probing the Chemical Stability of Mixed Ferrites: Implications for MR Contrast Agent Design |
| Q58089426 | Proposal to use superparamagnetic nanoparticles to test the role of cryptochrome in magnetoreception |
| Q38378507 | Quantifications of in vivo labeled stem cells based on measurements of magnetic moments |
| Q90393152 | Quantitative CT and 19F-MRI tracking of perfluorinated encapsulated mesenchymal stem cells to assess graft immunorejection |
| Q30497931 | Quantitative T2* imaging of metastatic human breast cancer to brain in the nude rat at 3 T |
| Q37229667 | Quantitative assessment of microvasculopathy in arcAβ mice with USPIO-enhanced gradient echo MRI |
| Q51047138 | Quantitative contrast-enhanced MRI with superparamagnetic nanoparticles using ultrashort time-to-echo pulse sequences. |
| Q92442221 | Radiolabeled PET/MRI Nanoparticles for Tumor Imaging |
| Q37414232 | Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation |
| Q31160257 | Rational design of protein-based MRI contrast agents |
| Q30541066 | Reaction-diffusion systems in intracellular molecular transport and control |
| Q37474623 | Real-time cardiac MRI without triggering, gating, or breath holding. |
| Q39077003 | Real-time infrared thermography detection of magnetic nanoparticle hyperthermia in a murine model under a non-uniform field configuration. |
| Q53074747 | Recent Development of Inorganic Nanoparticles for Biomedical Imaging. |
| Q38344555 | Recent advances in magnetic nanoparticle-based multi-modal imaging |
| Q37659410 | Recent developments in texaphyrin chemistry and drug discovery |
| Q48510837 | Recent progress in the use and tracking of transplanted islets as a personalized treatment for type 1 diabetes |
| Q30369384 | Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications |
| Q37307237 | Receptor-targeted nanoparticles for in vivo imaging of breast cancer |
| Q52863301 | Refinement of adsorptive coatings for fluorescent riboflavin-receptor-targeted iron oxide nanoparticles. |
| Q42555598 | Regulating exocytosis of nanoparticles via host-guest chemistry |
| Q33832576 | Release activation of iron oxide nanoparticles: (REACTION) a novel environmentally sensitive MRI paradigm |
| Q41332590 | Rescheduling the process of nanoparticle removal used for water mercury remediation can increase the risk to aquatic organism: evidence of innate immune functions modulation in European eel (Anguilla anguilla L.). |
| Q33415333 | Responsive MRI agents for sensing metabolism in vivo |
| Q30575244 | Rigid Mn(II) chelate as efficient MRI contrast agent for vascular imaging |
| Q34564111 | Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis |
| Q36233215 | Saposin C coupled lipid nanovesicles enable cancer-selective optical and magnetic resonance imaging |
| Q36059197 | Selective assembly of Au-Fe3O4 nanoparticle hetero-dimers. |
| Q34421475 | Self-organized Mn(2+)-Block Copolymer Complexes and Their Use for In Vivo MR Imaging of Biological Processes. |
| Q33446262 | Self-refocused spatial-spectral pulse for positive contrast imaging of cells labeled with SPIO nanoparticles |
| Q41883594 | Sensitive and efficient detection of thrombus with fibrin-specific manganese nanocolloids. |
| Q39370005 | Sensitivity of susceptibility-weighted imaging in detecting superparamagnetic iron oxide-labeled mesenchymal stem cells: a comparative study |
| Q38269215 | Silica-based nanoparticles: a versatile tool for the development of efficient imaging agents. |
| Q28487372 | Simple SPION incubation as an efficient intracellular labeling method for tracking neural progenitor cells using MRI |
| Q81422403 | Simultaneous dynamic T1 and T2* measurement for AIF assessment combined with DCE MRI in a mouse tumor model |
| Q36765663 | Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging |
| Q57559432 | Single-cell detection by gradient echo 9.4 T MRI: a parametric study |
| Q47444374 | Size control of magnetite nanoparticles in excess ligands as a function of reaction temperature and time. |
| Q42268414 | Size reproducibility of gadolinium oxide based nanomagnetic particles for cellular magnetic resonance imaging: effects of functionalization, chemisorption and reaction conditions |
| Q42507904 | Skin cancer: symptoms, mechanistic pathways and treatment rationale for therapeutic delivery |
| Q31141729 | Small animal imaging with magnetic resonance microscopy |
| Q38023802 | Smart polymersomes for therapy and diagnosis: fast progress toward multifunctional biomimetic nanomedicines |
| Q33607091 | Solid MRI contrast agents for long-term, quantitative in vivo oxygen sensing |
| Q38226377 | Solid silica nanoparticles: applications in molecular imaging |
| Q49122473 | Spatio-temporal dynamics, differentiation and viability of human neural stem cells after implantation into neonatal rat brain |
| Q37088905 | Special cells, special considerations: the challenges of bringing embryonic stem cells from the laboratory to the clinic |
| Q26765843 | Stem Cell Imaging: Tools to Improve Cell Delivery and Viability |
| Q37157684 | Stem cell labeling for magnetic resonance imaging |
| Q34786978 | Stem cell therapy: MRI guidance and monitoring |
| Q33848165 | Stem cell tracking by nanotechnologies |
| Q42137997 | Stem cells as a tool for breast imaging |
| Q38617018 | Stimuli-responsive nanogel composites and their application in nanomedicine |
| Q33292585 | Study on the endocytosis and the internalization mechanism of aminosilane-coated Fe3O4 nanoparticles in vitro |
| Q53062229 | Studying the Effect of a Composition of the Cluster Core in High-Radiopacity Cluster Complexes of Rhenium on Their Acute Toxicity In Vivo. |
| Q37777384 | Superparamagnetic Iron Oxide Labeling of Stem Cells for MRI Tracking and Delivery in Cardiovascular Disease |
| Q57340453 | Superparamagnetic Iron Oxide Nanoparticles for MRI |
| Q37986729 | Superparamagnetic iron oxide (SPIO) labeling efficiency and subsequent MRI tracking of native cell populations pertinent to pulmonary heart valve tissue engineering studies |
| Q39676126 | Superparamagnetic iron oxide nanoparticle-labeled cells as an effective vehicle for tracking the GFP gene marker using magnetic resonance imaging |
| Q37090408 | Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking |
| Q38668514 | Superparamagnetic iron oxide nanoparticles for MR imaging of pancreatic cancer: Potential for early diagnosis through targeted strategies |
| Q27342892 | Superparamagnetic iron oxide nanoparticles function as a long-term, multi-modal imaging label for non-invasive tracking of implanted progenitor cells |
| Q30465367 | Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. |
| Q90539208 | Superparamagnetic iron oxides as MPI tracers: A primer and review of early applications |
| Q37676088 | Surface engineered antifouling optomagnetic SPIONs for bimodal targeted imaging of pancreatic cancer cells |
| Q50283243 | Surface functionalization of superparamagnetic nanoparticles for the development of highly efficient magnetic resonance probe for macrophages |
| Q33982646 | Susceptibility gradient quantization by MRI signal response mapping (SIRMA) to dephaser |
| Q36223384 | Synergistic enhancement of iron oxide nanoparticle and gadolinium for dual-contrast MRI. |
| Q47100910 | Synthesis and In Vitro Characterization of Fe3+-Doped Layered Double Hydroxide Nanorings as a Potential Imageable Drug Delivery System |
| Q38559085 | Synthesis of 64Cu(II)-bis(dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: in vivo evaluation as dual-modality PET-MRI agent |
| Q36922718 | Synthesis of Complexable Fluorescent Superparamagnetic Iron Oxide Nanoparticles (FL SPIONs) and Cell Labeling for Clinical Application |
| Q57258881 | Synthesis of Uniformly Sized Manganese Oxide Nanocrystals with Various Sizes and Shapes and Characterization of Their T1 Magnetic Resonance Relaxivity |
| Q37706245 | Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer |
| Q38896092 | Synthesis of multifunctional nanocomposites and their application in imaging and targeting tumor cells in vitro |
| Q34127829 | Synthesis of β-cyclodextrin conjugated superparamagnetic iron oxide nanoparticles for selective binding and detection of cholesterol crystals |
| Q52558358 | Synthesis, Stability and Relaxivity of TEEPO-Met: An Organic Radical as a Potential Tumour Targeting Contrast Agent for Magnetic Resonance Imaging. |
| Q37754141 | Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles |
| Q58575130 | Targeted Molecular Magnetic Resonance Imaging Detects Brown Adipose Tissue with Ultrasmall Superparamagnetic Iron Oxide |
| Q34139484 | Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer |
| Q37319940 | Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy |
| Q36157045 | Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances |
| Q27010317 | Targeted nanotechnology for cancer imaging |
| Q41808085 | Targeted transplantation of iron oxide-labeled, adipose-derived mesenchymal stem cells in promoting meniscus regeneration following a rabbit massive meniscal defect |
| Q38928745 | Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: a full study to provide the proof of principle from in vitro to in vivo. |
| Q36642702 | Targeting angiogenesis versus myogenesis with cardiac cell therapy |
| Q35168522 | Targeting multiple types of tumors using NKG2D-coated iron oxide nanoparticles. |
| Q55438557 | Temporal window for detection of inflammatory disease using dynamic cell tracking with time-lapse MRI. |
| Q37438398 | The Effectiveness of Ferritin as a Contrast Agent for Cell Tracking MRI in Mouse Cancer Models. |
| Q31009143 | The MRI marker gene MagA attenuates the oxidative damage induced by iron overload in transgenic mice |
| Q38069962 | The application of super paramagnetic iron oxide-labeled mesenchymal stem cells in cell-based therapy |
| Q36486409 | The fabrication of uniform cylindrical nanoshells and their use as spectrally tunable MRI contrast agents |
| Q28392957 | The interaction of sterically stabilized magnetic nanoparticles with fresh human red blood cells |
| Q30567453 | The use of gadolinium-carbon nanostructures to magnetically enhance stem cell retention for cellular cardiomyoplasty |
| Q30937214 | Theranostic Magnetic Nanostructures (MNS) for Cancer. |
| Q38459148 | Theranostic probe based on lanthanide-doped nanoparticles for simultaneous in vivo dual-modal imaging and photodynamic therapy |
| Q40475351 | Three-dimensional reconstruction of a vascular network by dynamic tracking of magnetite nanoparticles. |
| Q37222810 | Three-dimensional, in vivo MRI with self-gating and image coregistration in the mouse |
| Q37385444 | Toxicity of therapeutic nanoparticles |
| Q26785642 | Tracking Transplanted Stem Cells Using Magnetic Resonance Imaging and the Nanoparticle Labeling Method in Urology |
| Q38103222 | Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging |
| Q37455363 | Tracking immune cells in vivo using magnetic resonance imaging |
| Q91955604 | Tracking mesenchymal stem cells using magnetic resonance imaging |
| Q30443013 | Tracking of stem cells in vivo for cardiovascular applications |
| Q42955563 | Tracking of transplanted mesenchymal stem cells labeled with fluorescent magnetic nanoparticle in liver cirrhosis rat model with 3-T MRI |
| Q37862672 | Tracking stem cells using magnetic nanoparticles |
| Q39128194 | Tracking stem cells with superparamagnetic iron oxide nanoparticles: perspectives and considerations. |
| Q37479807 | Tracking the migration of cardially delivered therapeutic stem cells in vivo: state of the art. |
| Q40334464 | Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation |
| Q46288426 | Transient widespread blood-brain barrier alterations after cerebral photothrombosis as revealed by gadofluorine M-enhanced magnetic resonance imaging |
| Q39159310 | Tumour cell labelling by magnetic nanoparticles with determination of intracellular iron content and spatial distribution of the intracellular iron. |
| Q38126327 | Tuning the magnetic properties of nanoparticles. |
| Q51719676 | Tuning the relaxation rates of dual-mode T(1)/T(2) nanoparticle contrast agents: a study into the ideal system. |
| Q47686179 | Two decades of dendrimers as versatile MRI agents: a tale with and without metals |
| Q41254758 | Two novel direct SPIO labels and in vivo MRI detection of labeled cells after acute myocardial infarct |
| Q42322015 | T₁-MRI Fluorescent Iron Oxide Nanoparticles by Microwave Assisted Synthesis |
| Q48938323 | Ultra-small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI. |
| Q57395278 | Ultrasmall Water-Soluble and Biocompatible Magnetic Iron Oxide Nanoparticles as Positive and Negative Dual Contrast Agents |
| Q30834900 | Ultrasmall, Water-Soluble Magnetite Nanoparticles with High Relaxivity for Magnetic Resonance Imaging |
| Q37477701 | Umbilical cord mesenchymal stem cells labeled with multimodal iron oxide nanoparticles with fluorescent and magnetic properties: application for in vivo cell tracking. |
| Q33650578 | Unambiguous identification of superparamagnetic iron oxide particles through quantitative susceptibility mapping of the nonlinear response to magnetic fields |
| Q36463444 | Utilizing the folate receptor for active targeting of cancer nanotherapeutics |
| Q38957484 | Vascular targeting of nanoparticles for molecular imaging of diseased endothelium |
| Q35403421 | Visual bone marrow mesenchymal stem cell transplantation in the repair of spinal cord injury |
| Q84587282 | WITHDRAWN: Inorganic nanoparticles for cancer imaging and therapy |
| Q31108239 | Water diffusion-exchange effect on the paramagnetic relaxation enhancement in off-resonance rotating frame |
| Q41621842 | Well-defined, multifunctional nanostructures of a paramagnetic lipid and a lipopeptide for macrophage imaging. |
| Q31146798 | Wrap-bake-peel process for nanostructural transformation from beta-FeOOH nanorods to biocompatible iron oxide nanocapsules |
| Q94589631 | [T1-weighted magnetic resonance imaging contrast agents and their theranostic nanoprobes] |
Search more.